- Sold all assets and IP of subsidiary Tissue Health Plus, LLC to an unrelated party.
- Purchase price is approximately $2.0M in cash plus potential earnout rights.
- Modest liquidity inflow; non-core asset divestment.
?? Positive AI Sentiment (+1.5 / 10)
Single signal · #45397
Public delayed archive entry for this Stock Catalyst AI alert.